Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1159/000514467 http://scihub22266oqcxt.onion/10.1159/000514467 33752209!8089440!33752209     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Blood+Purif 2021 ; 50 (6): 740-749 Nephropedia Template TP {{tp|p=33752209|t=2021. COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors |pdf=|usr=}}{{33752209}} gab.com Text COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors JO: Blood Purif http://www.kidney.de/pget.php?&tw=1&pmid=33752209 #FOAvip Cardiovascular disease is a frequent complication and the most common cause of death in patients with CKD. Despite landmark medical advancements, mortality due to cardiovascular disease is still 20 times higher in CKD patients than in the general population, which is mainly due to the high prevalence of risk factors in this group. Indeed, in addition to traditional cardiovascular risk factors, CKD patients are exposed to nontraditional ones, which include metabolic, hormonal, and inflammatory alterations. The global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has brought novel challenges for both cardiologists and nephrologists alike. Emerging evidence indicates that coronavirus disease 2019 (COVID-19) increases the risk of cardiovascular events and that several aspects of the disease may synergize with pre-existing cardiovascular risk factors in CKD patients. A better understanding of these mechanisms is pivotal for the prevention and treatment of cardiovascular events in this context, and we believe that additional clinical and experimental studies are needed to improve cardiovascular outcomes in CKD patients with COVID-19. In this review, we provide a summary of traditional and nontraditional cardiovascular risk factors in CKD patients, discussing their interaction with SARS-CoV-2 infection and focusing on CO-VID-19-related cardiovascular complications that may severely affect short- and long-term outcomes in this high-risk population. Twit Text FOAVip COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors ????Blood Purif http://www.kidney.de/pget.php?&tw=1&pmid=33752209 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33752209 #FOAvip English Wikipedia <ref>{{Cite pmid|33752209}}</ref> COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors #MMPMID33752209 Podesta MA; Valli F; Galassi A; Cassia MA; Ciceri P; Barbieri L; Carugo S; Cozzolino M Blood Purif 2021[]; 50 (6): 740-749 PMID33752209show ga Cardiovascular disease is a frequent complication and the most common cause of death in patients with CKD. Despite landmark medical advancements, mortality due to cardiovascular disease is still 20 times higher in CKD patients than in the general population, which is mainly due to the high prevalence of risk factors in this group. Indeed, in addition to traditional cardiovascular risk factors, CKD patients are exposed to nontraditional ones, which include metabolic, hormonal, and inflammatory alterations. The global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has brought novel challenges for both cardiologists and nephrologists alike. Emerging evidence indicates that coronavirus disease 2019 (COVID-19) increases the risk of cardiovascular events and that several aspects of the disease may synergize with pre-existing cardiovascular risk factors in CKD patients. A better understanding of these mechanisms is pivotal for the prevention and treatment of cardiovascular events in this context, and we believe that additional clinical and experimental studies are needed to improve cardiovascular outcomes in CKD patients with COVID-19. In this review, we provide a summary of traditional and nontraditional cardiovascular risk factors in CKD patients, discussing their interaction with SARS-CoV-2 infection and focusing on CO-VID-19-related cardiovascular complications that may severely affect short- and long-term outcomes in this high-risk population. |Animals[MESH] |COVID-19/*complications[MESH] |Cardiovascular Diseases/*etiology[MESH] |Heart Disease Risk Factors[MESH] |Humans[MESH] |Renal Insufficiency, Chronic/*complications[MESH]COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardio(epmc).pdf DeepDyve Pubget Overpricing